Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Chinese Patent Office
Express Scripts
Farmers Insurance
US Department of Justice

Generated: October 22, 2017

DrugPatentWatch Database Preview

RHINOCORT Drug Profile

« Back to Dashboard

Which patents cover Rhinocort, and when can generic versions of Rhinocort launch?

Rhinocort is a drug marketed by Astrazeneca and Astrazeneca Pharms and is included in two NDAs.

The generic ingredient in RHINOCORT is budesonide. There are twenty drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the budesonide profile page.

Summary for Tradename: RHINOCORT

US Patents:0
Bulk Api Vendors: see list84
Clinical Trials: see list7
Patent Applications: see list9,663
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RHINOCORT at DailyMed

Pharmacology for Tradename: RHINOCORT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
AEROSOL, METERED;NASAL020233-001Feb 14, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca Pharms
SPRAY, METERED;NASAL020746-003Mar 23, 2015OTCYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for RHINOCORT

Drugname Dosage Strength RLD Submissiondate
budesonideNasal Spray0.032 mg (32 mcg)/sprayRhinocort5/14/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Farmers Insurance
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus